Join now & save up to 80% on medication

JOIN NOW
Select Language:

Join now and save 80% on medication

Register/Login

Micardis Plus

Please note: a valid prescription is required for all prescription medication.

Total:
Each:

Micardis Plus combines the therapeutic effects of telmisartan, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a thiazide diuretic, to provide a powerful treatment for high blood pressure (hypertension). Hypertension often requires a multifaceted approach to management, and Micardis Plus offers the benefits of two medications in one convenient tablet. Telmisartan helps relax blood vessels by blocking the action of angiotensin II, while hydrochlorothiazide works by reducing the amount of excess fluid in the body, thereby lowering blood pressure. This combination not only enhances the blood pressure-lowering effect but also provides added protection against cardiovascular events. For patients who need more than one medication to control their blood pressure effectively, Micardis Plus offers a simplified regimen with combined benefits, promoting better adherence and outcomes in hypertension management.

Benefits of Micardis Plus:

  • Effectively lowers blood pressure.
  • Reduces the risk of cardiovascular events.
  • Combines two medications for enhanced efficacy.

Dosage:

  • Typical starting dose: One tablet once daily.
  • Dose adjusted based on individual response.

Warnings and Precautions:

  • Avoid use during pregnancy.
  • Use with caution in patients with kidney or liver issues.
  • Monitor electrolyte levels regularly.

Usage Instructions:

  • Take Micardis Plus with or without food.
  • Follow your doctor’s instructions regarding dosing and timing.

Storage Information:

  • Store at room temperature, between 68°F and 77°F (20°C to 25°C).
  • Keep in its original container, away from moisture and light.

Common Side Effects:

  • Dizziness or lightheadedness.
  • Electrolyte imbalances.
  • Increased urination.

Express Shipping - from $25.00

Shipping with this method takes 3-5 days

Prices:
  • Dry-Packed Products $25.00
  • Cold-Packed Products $35.00

Standard Shipping - $15.00

Shipping with this method takes 5-10 days

Prices:
  • Dry-Packed Products $15.00
  • Not available for Cold-Packed products

Rewards Program

Earn points on birthdays, product orders, reviews, friend referrals, and more! Enjoy your medication at unparalleled discounts while reaping rewards for every step you take with us.

You can read more about rewards here.

POINT VALUE

100 points
1 USD

How to earn points

  • 1Register and/or Login
    Create an account and start earning.
  • 2Earn Rewards
    Earn points every time you shop or perform certain actions.
  • 3Redeem
    Redeem points for exclusive discounts.

You Might Also Like

Micardis

$67.50
You save

  • In Stock
  • Express Shipping
Select options This product has multiple variants. The options may be chosen on the product page

Related Articles

Weight Loss
Top 10 Weight Loss Tips That Actually Work

Shedding extra pounds is a personal journey, not a one-size-fits-all process. While many people seek quick weight loss tips, the truth is that lasting changes come from small, sustainable habits.…

Read More
Weight Loss
Wegovy Doses: A Complete Guide to Weekly Injections

Wegovy (semaglutide) has changed the landscape of weight loss treatments, offering patients a once-weekly injection that helps regulate appetite and support long-term weight management. But for those just starting out,…

Read More
Weight Loss
Tirzepatide vs Semaglutide: How They Compare for Weight Loss

Obesity medicine has changed fast over the past three years. Two once-weekly injections, Tirzepatide (brands Mounjaro and Zepbound) and Semaglutide (Ozempic and Wegovy), promise to trim pounds, curb appetite, and…

Read More
Weight Loss
What Is the Best Injection for Weight Loss in 2025? Find Out Here

With rising global obesity rates, more people are turning to non-invasive medical solutions for weight loss. As the need for effective and sustainable approaches continues to rise, one question remains…

Read More